Showing results (21-30 of 32) with videos related to
Sort By:
Pageof 4
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 18, 2011
Enhanced immune response after a second dose of an AS03-adjuvanted H1N1 influenza A vaccine in patients after hematopoietic stem cell transplantationSaskia Gueller, Regina Allwinn, Sabine Mousset, et al.American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|May 15, 2014
Nephropathy in illicit drug abusers: a postmortem analysisMaike Buettner, Stefan W Toennes, Stefan Buettner, et al.Sexually Transmitted Diseases|June 10, 2010
Prevalence- and gender-specific immune response to opportunistic infections in HIV-infected patients in LesothoHolger F Rabenau, Tessa Lennemann, Claudia Kircher, et al.Plos Pathogens|July 3, 2013
Dissection of antibody specificities induced by yellow fever vaccinationOksana Vratskikh, Karin Stiasny, Jürgen Zlatkovic, et al.HIV Clinical Trials|August 9, 2013
Immune response after a single dose of the 2010/11 trivalent, seasonal influenza vaccine in HIV-1-infected patients and healthy controlsMarkus Bickel, Christin Lassmann, Imke Wieters, et al.Hepatology (Baltimore, Md.)|May 25, 2013
Low vitamin D serum concentration is associated with high levels of hepatitis B virus replication in chronically infected patientsHarald Farnik, Jörg Bojunga, Annemarie Berger, et al.BMJ (Clinical Research Ed.)|November 8, 2003
Tolerability of malaria chemoprophylaxis in non-immune travellers to sub-Saharan Africa: multicentre, randomised, double blind, four arm studyPatricia Schlagenhauf, Alois Tschopp, Richard Johnson, et al.Scandinavian Journal of Infectious Diseases|July 9, 2014
Durability of protective antibody titres is not enhanced by a two-dose schedule of an ASO3-adjuvanted pandemic H1N1 influenza vaccine in adult HIV-1-infected patientsMarkus Bickel, Corinna Lais, Imke Wieters, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 15, 2010
Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patientsMarkus Bickel, Nils von Hentig, Imke Wieters, et al.AIDS (London, England)|June 19, 2010
Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patientsMarkus Bickel, Imke Wieters, Pavel Khaykin, et al.Pageof 4